European Journal of Epidemiology:每天60毫克蔬菜硝酸盐,远离心血管疾病

2021-05-09 MedSci原创 MedSci原创

这项对53150名基线时无心血管疾病的丹麦人进行的前瞻性队列研究发现基线时较高的蔬菜硝酸盐摄入量与较低的收缩压和舒张压相关。此外,还观察到,适量摄入蔬菜硝酸盐与心血管疾病的发生呈负相关。

Catherine P. Bondonno等近期在European Journal of Epidemiology发表了一项前瞻性队列研究结果,对超过5万名受试者进行了20多年的随访以分析蔬菜硝酸盐(主要的饮食硝酸盐来源)摄入与血压及血管疾病(CVD)风险的关联进行了研究,结果提示,每天至少食用约60毫克的蔬菜硝酸盐(~ 1杯绿叶蔬菜)或可降低心血管疾病的风险。

在临床试验中观察到的无机硝酸盐的血管效应是否可通过减少饮食中的习惯性硝酸盐摄入而减少心血管疾病(CVD),值得进一步研究。该研究旨在确定植物硝酸盐(饮食中主要的硝酸盐来源)是否与降低血压(BP)和降低发生CVD的风险有关。在基线无CVD的丹麦饮食,癌症和健康研究的53150名参与者中,使用综合性植物硝酸盐数据库评估了植物硝酸盐的摄入量。基于多变量调整的Cox比例风险模型,计算了风险比(HRs)。在随访的23年中,共记录了14,088例CVD病例。与蔬菜硝酸盐摄入量最低五分位数参与者相比,蔬菜硝酸盐摄入量最高五分位数的的参与者(中位数为141 mg /天)基线收缩压降低了2.58 mmHg(95%CI-3.12,-2.05),舒张压降低了1.38 mmHg(95%CI-1.66,-1.10)。在中等摄入量(〜60 mg /天)下,蔬菜硝酸盐的摄入量与CVD稳定期呈负相关。这似乎是由收缩压(21.9%)介导的。

蔬菜硝酸盐摄入量与CVD发病率及CVD亚型(缺血性心脏病、缺血性中风、出血性中风、心力衰竭、外周动脉疾病、心房颤动)发病率的关系。风险比是基于Cox比例危害模型,该模型根据年龄、性别、BMI、吸烟状况、身体活动、酒精摄入量、教育程度、社会经济状况(收入)、婚姻状况、高胆固醇血症、糖尿病、慢性阻塞性肺病、慢性肾脏病和癌症患者的具体蔬菜硝酸盐摄入量水平(横轴)与最低摄入五分位数参与者的中位数摄入量(23毫克/天)进行比较。

按性别、基线BMI、吸烟状态或酒精摄入量分层的蔬菜硝酸盐总摄入量与心血管疾病发生率之间的多变量调整相关性。基于Cox比例危害模型的风险比,比较了蔬菜硝酸盐摄入量的具体水平(横轴)和最低摄入五分位数参与者的中位数摄入量(23毫克/天)。所有分析都根据年龄、性别、BMI、吸烟状况、身体活动(每日代谢当量)、纯酒精摄入量(克/天)、社会经济状况(收入)、婚姻状况、高胆固醇血症(是否)、教育程度和流行疾病(糖尿病、慢性阻塞性肺病、慢性肾病和癌症;单独进入模型)

 

与最低五分位数摄入量(中位数23mg/天)的参与者相比,适量的蔬菜硝酸盐摄入量(中位数59毫克/天)与CVD风险降低15%[HR(95%CI)0.85(0.82,0.89)]相关。摄入适量的蔬菜硝酸盐可使缺血性心脏病、心力衰竭、缺血性中风和周围动脉疾病的住院风险分别降低12%、15%、17%和26%。每天至少摄入约60毫克的蔬菜硝酸盐(约1杯绿叶蔬菜)可以减轻CVD的风险。

综上,这项对53150名基线时无心血管疾病的丹麦人进行的前瞻性队列研究发现基线时较高的蔬菜硝酸盐摄入量与较低的收缩压和舒张压相关。此外,还观察到,适量摄入蔬菜硝酸盐与心血管疾病的发生呈负相关,而摄入更多则没有额外的益处。这种关联部分是由收缩压介导的,并且在高饮酒量的个体中比那些低到中等饮酒量的个体中更强。对于CVD亚型,中到高硝酸盐蔬菜摄入量的个体动脉粥样硬化性CVD(IHD、缺血性卒中、心力衰竭和PAD)住院的风险较低,但对于其他CVD(出血性卒中或房颤)住院的风险不高

原文出处

Bondonno, C.P., Dalgaard, F., Blekkenhorst, L.C. et al. Vegetable nitrate intake, blood pressure and incident cardiovascular disease: Danish Diet, Cancer, and Health Study. Eur J Epidemiol (2021). https://doi.org/10.1007/s10654-021-00747-3

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-10-15 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-13 paperyu
  4. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-10 氟西西

    调整的基线变量值得参考

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-09 120e0b45m85(暂无昵称)

    积分

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-09 ms3000001139571985

    吼吼

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-09 jyzxjiangqin

    好文章!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-09 ms2000001361349190

    学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1898706, encodeId=6f781898e066a, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jun 03 16:27:27 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728937, encodeId=1e501e289371d, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Oct 15 12:27:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756261, encodeId=c4f81e562617a, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Thu May 13 04:27:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498872, encodeId=22f214988e260, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue May 11 08:27:27 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964210, encodeId=ef999642108a, content=调整的基线变量值得参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon May 10 09:15:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964062, encodeId=f9da96406212, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71382214290, createdName=120e0b45m85(暂无昵称), createdTime=Sun May 09 19:19:20 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964038, encodeId=01c99640387d, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/53891cfa36f846c4ab4da2d139935ae3/6f5c2cbd54664c16a331cd1003bd8289.jpg, createdBy=21925496322, createdName=ms3000001139571985, createdTime=Sun May 09 17:55:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964031, encodeId=6d299640314a, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 09 17:49:59 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964021, encodeId=d44996402195, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 09 17:45:52 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964019, encodeId=e7fc96401967, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a55436076, createdName=ms7000001713024874, createdTime=Sun May 09 17:45:03 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-09 ms7000001713024874

    谢谢

    0

相关资讯

JAHA:加强对血压升高的处理与卒中复发风险的关系

低TI评分意味着医生在患者血压管理方面存在治疗惰性,与卒中复发的高风险相关。TI评分可能是门诊一个有用的指标,以防止卒中复发。

Ann Rheum Dis:使用维生素K拮抗剂与骨关节炎发病和进展的风险升高相关

这些发现支持了维生素K和维生素K依赖性蛋白(如MGP)在OA发病中的重要性。

Stroke:自主神经失调与痴呆和卒中风险的关系

心脏自主神经失调发生于痴呆和卒中之前,尤其是在老年人和男性中。

Alzheimer Dementia :中年时控制血压可降低痴呆风险

中年时控制血压可降低痴呆风险

JCEM:血浆皮质醇与房颤风险的关系

房颤、心律失常及相关危险因素在库欣综合征或慢性高皮质醇症患者中很常见。来自MR研究的证据表明血浆皮质醇水平与房颤风险之间呈正相关,并可能通过SBP和WC所介导。

JAHA:不良童年经历与成年后冠心病风险的关系

抑郁症状、焦虑症状和心脏代谢异常在一定程度上介导了ACEs与冠心病之间的关系。定期筛查和治疗心理疾病和心脏代谢异常的症状可能有助于减轻ACE的长期健康负担。